TiffanyYung-ChinChangMD

Clinical Fellow, Pediatrics, UCSF School of Medicine

Are you Dr. Chang?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 60 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Office
505 Parnassus Ave
Box 0106
San Francisco, CA 94143
Phone+1 415-476-3831
Is this information wrong?

Dr. Tiffany Chang, MD is a pediatric hematologist/oncologist in San Francisco, California. She is currently licensed to practice medicine in California, Illinois, and Indiana. She is a Clinical Fellow at UCSF School of Medicine.

University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2009 - 2012
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 2006 - 2009
University of California, Irvine, School of MedicineClass of 2006

PubMed

23 citations
Prophylactic emicizumab for hemophilia A in the Asia-Pacific region: A randomized study (HAVEN 5).
Renchi Yang, Shujie Wang, Xuefeng Wang, Jing Sun, Ampaiwan Chuansumrit, Jianfeng Zhou, Christophe Schmitt, Wanling Hsu, Jeffrey Xu, Lindong Li, Tiffany Chang, Xielan Zhao> ;Research and Practice in Thrombosis and Haemostasis. 2022 Feb 1
6 citations
Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database
Steven W. Pipe, Rebecca Kruse-Jarres, Johnny Mahlangu, Glenn F. Pierce, Flora Peyvandi, Peter J. Kuebler, Christian De Ford, Fabian Sanabria, Richard H. Ko, Tiffany Ch...> ;Journal of Thrombosis and Haemostasis. 2021 Jan 1
Selective Sentinel Lymph Node Dissection in Lower Extremity Melanoma.
Miranda, S. G.,Parrett, B. M.,Li, R. R.,Lee, G.,Chang, T.,Fadaki, N.,Cardona-Huerta, S.,Cleaver, J. E.,Kashani-Sabet, M.,Leong, S. P.> ;Plast. Reconstr. Surg.. 2016 Jan 26
Abstract 17: selective sentinel lymph node dissection in lower extremity melanoma.
Miranda, S. G.,Li, R.,Parrett, B.,Lee, G.,Thumala, S.,Chang, T.,Fadaki, N.,Cardona-Huerta, S.,Cheng, S. T.,Cleaver, J.,Kashani-Sabet, M.,Leong, S.> ;Plast. Reconstr. Surg.. 2014 Mar 29
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.
Chang, T.,Krisman, K.,Theobald, E. H.,Xu, J.,Akutagawa, J.,Lauchle, J. O.,Kogan, S.,Braun, B. S.,Shannon, K.> ;J. Clin. Invest.. 2012 Dec 12
Join now to see all